000			01772 a2200493 4500
005			20250515204000.0
264		0	_c20100601
008			201006s 0 0 eng d
022			_a1873-2747
024	7		_a10.1016/j.brainresbull.2010.01.009 _2doi
040			_aNLM _beng _cNLM
100	1		_aWalsh, Sinéad
245	0	0	_aLoss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat. _h[electronic resource]
260			_bBrain research bulletin _cApr 2010
300			_a543-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic Agents _xtoxicity
650	0	4	_aAnimals
650	0	4	_aAxons _xdrug effects
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aGene Expression
650	0	4	_aMale
650	0	4	_aMedial Forebrain Bundle _xdrug effects
650	0	4	_aNerve Degeneration _xchemically induced
650	0	4	_aNeurons _xdrug effects
650	0	4	_aOrgan Size
650	0	4	_aOxidopamine _xtoxicity
650	0	4	_aParkinson Disease
650	0	4	_aParkinsonian Disorders _xchemically induced
650	0	4	_aRandom Allocation
650	0	4	_aRats
650	0	4	_aReceptor, Cannabinoid, CB1 _xgenetics
650	0	4	_aSubstantia Nigra _xmetabolism
650	0	4	_aTime Factors
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
700	1		_aMnich, Katarzyna
700	1		_aMackie, Ken
700	1		_aGorman, Adrienne M
700	1		_aFinn, David P
700	1		_aDowd, Eilís
773	0		_tBrain research bulletin _gvol. 81 _gno. 6 _gp. 543-8
856	4	0	_uhttps://doi.org/10.1016/j.brainresbull.2010.01.009 _zAvailable from publisher's website
999			_c19473678 _d19473678